The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
PLoS One. 2021 May 27;16(5):e0251584. doi: 10.1371/journal.pone.0251584. eCollection 2021.
Hyperbilirubinemia is a common disease in the neonatal period, and hyperbilirubinemia may cause brain damage. Therefore, prevention and diagnosis and management of hyperbilirubinemia is very important, and vitamin D may affect bilirubin levels. To evaluate the relationship between neonatal hyperbilirubinemia and vitamin D levels.
The China National Knowledge Infrastructure, VIP, Wanfang, Chinese Biology Medicine Disc, PubMed, Web of Science, Cochrane Library, and Embase databases as well as clinical trial registries in China and the United States were searched for relevant studies from inception to September 2020 without restrictions on language, population, or year. The studies was screened by two reviewers independently, the data were extracted, and the risk of bias of the included studies was evaluated using the NOS. A meta-analysis was conducted on the included studies using Stata11 software.
Six case-control studies were included, and the methodological quality of the studies was high (grade A). The studies included 690 newborns; more than 409 were diagnosed with hyperbilirubinemia. The means and standard deviations were calculated. Meta-analysis results showed that neonatal vitamin D levels were 7.1 ng/ml lower among infants with hyperbilirubinemia than among healthy newborn levels (z = 6.95, 95% CI 9.10 ~ 5.09, P < 0.05). Subgroup analysis was conducted based on whether the bilirubin levels were concentrated in the 15 to 20 mg/dl range. Vitamin D level of infants with hyperbilirubinemia (the bilirubin levels were concentrated in the 15 to 20 mg/dl range) was 9.52 ng/ml (Z = 15.55, 95% CI-10.72-8.32, P<0.05) lower than that of healthy infants. The bilirubin levels in four cases were not concentrated in the 15-20 mg/dl range. The results showed that the vitamin D level of hyperbilirubinemia (The bilirubin levels were not concentrated in the 15-20 mg/dl range) neonates were 5.35 ng/ml lower than that of healthy neonates (Z = 6.43, 95% CI-6.98-3.72, P<0.05).
Vitamin D levels were observed to be lower in neonates with hyperbilirubinemia as compared to term neonates without hyperbilirubinemia in this study. This can possibly suggest that neonates with lower vitamin D levels are at higher risk for developing hyperbilirubinemia.
高胆红素血症是新生儿期的一种常见疾病,高胆红素血症可能导致脑损伤。因此,预防、诊断和管理高胆红素血症非常重要,维生素 D 可能影响胆红素水平。评估新生儿高胆红素血症与维生素 D 水平之间的关系。
检索中国知网、维普、万方、中国生物医学文献数据库、PubMed、Web of Science、Cochrane 图书馆、Embase 数据库,以及中美临床试验注册库,全面收集建库至 2020 年 9 月有关新生儿高胆红素血症与维生素 D 水平关系的研究,语种不限,研究对象为人群不限,类型不限。由 2 位评价员独立筛选文献、提取资料并评价纳入研究的偏倚风险,采用 Stata11 软件进行 Meta 分析。
共纳入 6 项病例对照研究,研究质量均较高(A级)。共纳入 690 例新生儿,其中 409 例以上诊断为高胆红素血症,计算了均值和标准差。Meta 分析结果显示,高胆红素血症新生儿的维生素 D 水平比健康新生儿低 7.1ng/ml(z=6.95,95%CI 9.105.09,P<0.05)。基于胆红素水平是否集中在 1520mg/dl 范围内进行了亚组分析。高胆红素血症婴儿(胆红素水平集中在 1520mg/dl 范围内)的维生素 D 水平低 9.52ng/ml(Z=15.55,95%CI-10.72-8.32,P<0.05)。在另外 4 项研究中,胆红素水平未集中在 1520mg/dl 范围内。结果表明,高胆红素血症新生儿(胆红素水平未集中在 1520mg/dl 范围内)的维生素 D 水平比健康新生儿低 5.35ng/ml(Z=6.43,95%CI-6.98~-3.72,P<0.05)。
本研究显示,与无高胆红素血症的足月新生儿相比,高胆红素血症新生儿的维生素 D 水平较低,这可能表明维生素 D 水平较低的新生儿发生高胆红素血症的风险更高。